Guy Kantor

Radiotherapy for Glioblastoma in the Elderly

Florence Keime-Guibert, Olivier Chinot, Luc Taillandier et al. · New England Journal of Medicine · 2007 · 774 citations

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Brigitta G. Baumert, Monika E. Hegi, Martin J. van den Bent et al. · The Lancet Oncology · 2016 · 485 citations · Full text

Neuro-oncology, Glioma, Radiation Therapy +10

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · The Lancet Oncology · 2019 · 469 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +10

Prognostic factors in retroperitoneal sarcoma

Eberhard Stoeckle, Jean‐Michel Coindre, Sylvie Bonvalot et al. · Cancer · 2001 · 448 citations · Full text

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

Sylvie Bonvalot, C. Le Péchoux, Thierry de Baère et al. · Clinical Cancer Research · 2016 · 223 citations